HomeCAPR • NASDAQ
Follow
Capricor Therapeutics Inc
Previous close
$6.77
Day range
$6.60 - $6.94
Year range
$2.68 - $8.22
Market cap
213.20M USD
Avg Volume
351.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 12.09M | 1,159.30% |
Operating expense | -23.08M | -80.43% |
Net income | -762.09K | 90.13% |
Net profit margin | -6.30 | 99.22% |
Earnings per share | -0.02 | 91.82% |
EBITDA | -973.68K | 87.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 39.49M | -4.67% |
Total assets | 58.73M | 17.25% |
Total liabilities | 36.13M | -5.68% |
Total equity | 22.60M | — |
Shares outstanding | 31.40M | — |
Price to book | 9.27 | — |
Return on assets | -6.68% | — |
Return on capital | -25.16% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -762.09K | 90.13% |
Cash from operations | -11.59M | -67.98% |
Cash from investing | -5.86M | -214.01% |
Cash from financing | 23.17M | 685.45% |
Net change in cash | 5.71M | 380.01% |
Free cash flow | -11.40M | 22.32% |
About
CEO
Founded
2005
Headquarters
Website
Employees
102